Opendata, web and dolomites

Horizon2020 projects coordinated by "BIOVERSYS AG"

# project acronym  year  total cost  totalcontribution 
1 TRIC-TB Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. 2019 8˙373˙250.00 6˙926˙375.00

More Horizon 2020 projects

The Institution BIOVERSYS AG has been involved also in the following Horizon 2020 projects.